In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/rebrand-name-change-way-we-eat-and-save.html Rebranding programs have been asked to do a lot of things. But this Kat had never, until now, encountered a rebranding program whose goal is no less than to bring about fundamental culinary and ecological changes. The feline species is not known for its aversion to enjoying fish at... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/book-review-intellectual-property.html Having recently reviewed The Future of Copyright in the Age of Artificial Intelligence, here, this Kat continues thematic reviews in this area with a review of Intellectual Property Protection for AI-Generated Creations: Europe, United States, Australia and Japan, by Ana Ramalho (Copyright Counsel at Google, and a Guest Lecturer... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/thursday-thingies.html Time has been passing by very quickly, and it is time for another Thursday Thingies. This week, we bring to you some IPKat Team News as well as many upcoming events and opportunities. IPKat Team News James Kwong included amongst Managing IP’s Rising Stars 2022 To recognize the efforts... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/rethinking-academic-conferences.html Following the previous Katpost [here] which raised some questions about the effectiveness of academic conferences, I received a number of direct responses from readers leading to some constructive conversations on the topic. [A selection of anonymised quotes is provided below]. Thinking of solutions now! Image: Riana Harvey The overwhelming feeling... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/copyrighting-ogopogo-monster-story.html Kat friend Hugh Stephens describes the murky story of IP and the Ogopogo monster (“murky” as the waters in which the Ogopogo is said to dwell). The headline –“City of Vernon transfers copyright to legendary Ogopogo to B.C. Indigenous nations”–was featured in newspapers and broadcasts across Canada, based on... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/11/book-review-future-of-copyright-in-age.html Can artificial intelligence (AI) create things? Yes. AI has created movies such as Sunspring 2016, written novels like The Day a Computer Writes a Novel, and made art in the form of The Next Rembrandt. But-are those creations the same as human creations? Arguably not. For a start, all... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/10/easy-sanitary-solutions-v-group.html Kat readers interested in EU design law likely remember the textbook case concerning the validity of a design for a shower drain. This case, which reached the Court of Justice (CJEU) in 2017, discussed whether the same public shall be considered when examining novelty, and individual character a design,... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/10/book-review-ipec-practice-and-procedures.html This is a review of the third edition of The Intellectual Property Enterprise Court: Practice and Procedure by Angela Fox, partner at Maucher Jenkins and head of the UK Litigation and Dispute Resolution group. The previous edition of the book was published back in 2016, so there was... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/10/do-we-need-to-rethink-academic.html EPIP (European Policy for Intellectual Property) – as the website states – is an international, independent, interdisciplinary, non-profit association of researchers that grew out of a network financed by the European Commission in 2003-05. The annual EPIP conference took place from 14th – 16th September 2022, at Cambridge University... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2022/10/nilotinib-included-in-medicines-patent.html The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to allow generic drugmakers in seven middle income nations to develop, manufacture, and supply generic versions of the leukaemia treatment nilotinib. This new agreement was announced on the side-lines of the World Cancer Congress. The... Continue reading
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION